About TIBET EASTMONEY FU
Expense ratio
0.55%
Home page
Inception date
Apr 21, 2023
CSI Shanghai-Hong Kong-Shenzhen Innovative Drug Industry Index - CNY - Benchmark TR Gross
ISIN
CNE100005YZ1
Tightly track the target index, pursue the minimization of tracking deviation and tracking err.
Classification
What's in the fund
Exposure type
Health Technology
Stock breakdown by region